Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

This study has been completed.

Study NCT00334880 Information provided by New River Pharmaceuticals

First Received: June 7, 2006 Last Updated: July 1, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	November 2006
Estimated Primary Completion Date:	No date given